Celltrion obtains positive CHMP opinion for subcutaneous infliximab biosimilar

September 24, 2019
Celltrion received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use for the subcutaneous…
In the Journals

Adalimumab, IBI303 biosimilar demonstrate comparable safety, efficacy in AS

September 19, 2019
IBI303, a biosimilar to adalimumab developed by Chinese biopharmaceutical company Innovent Biologics, is comparable in safety and efficacy to the…
In the JournalsPerspective

ACR cautions against mandated biosimilar switching for AS, axSpA

August 22, 2019
Adults with active ankylosing spondylitis despite treatment with a first TNF-inhibitor, as well as those with stable disease receiving an originator…
FDA News

FDA approves Hadlima, fourth Humira biosimilar

July 24, 2019
The FDA has approved the fourth biosimilar to adalimumab, adalimumab-bwwd, for all eligible indications of the biologic product, according to a…
In the JournalsPerspective

Positive framing improves patients’ willingness to switch to biosimilar

July 11, 2019
Although patients express concerns regarding the safety and efficacy of biosimilars, physicians can improve willingness to switch to a biosimilar by…
FDA News

FDA approves Zirabev, biosimilar to Avastin

June 28, 2019
The FDA approved bevacizumab-bvzr for the treatment of metastatic colorectal cancer; unresectable, locally advanced, recurrent or metastatic…
FDA News

FDA approves Kanjinti, biosimilar to Herceptin

June 13, 2019
The FDA approved trastuzumab-anns for the treatment of HER2-overexpressing breast cancer, as well as metastatic gastric or gastroesophageal junction…
In the JournalsPerspective

No impact on safety, efficacy in etanercept-to-biosimilar switch in RA

June 12, 2019
Patients with moderate-to-severe rheumatoid arthritis who switch from etanercept to the biosimilar etanercept-szzs experienced no impacts on drug…

Battle for Enbrel: Ruling on patent lawsuit could transform US biosimilar marketplace

June 10, 2019
Amgen is currently embroiled in two pivotal court cases surrounding patents for its bestselling etanercept product that could protect it from…
Meeting News

US should ‘learn from Europe’ regarding biosimilar policy, adoption

May 16, 2019
CLEVELAND — The United States continues to lag far behind Europe in terms of biosimilar availability, and officials here should take a lesson…